A5008577893- Global Cancer Incidence and Screening
- CAR-T cell therapy research
- Food Security and Health in Diverse Populations
- Testicular diseases and treatments
- Advancements in Semiconductor Devices and Circuit Design
- transportation and logistics systems
- Semiconductor materials and devices
- Reproductive Biology and Fertility
- Sperm and Testicular Function
- Health disparities and outcomes
Northwestern University
2023-2025
Boston Medical Center
2025
Although social determinants of health (SDoH) investigations have shown limited analyses socioeconomic and race-ethnic status on certain hematologic malignancies, the impact factors beyond those across a fuller scope cancers remains unknown. The Social Vulnerability Index (SVI), tool for assessing varied US-census derived sociodemographic factors, allows specific quantification SDoH in dynamic, regional contexts their associations with hematologic-malignancy inequities. To assess summative...
Cardiovascular adverse events (CVAEs) are recognized complications of chimeric antigen receptor (CAR) T-cell therapies. However, data lacking regarding subtypes that develop in patients with different malignancies, and little is known about the timeframe which cardiotoxicities most likely to occur post-CAR In this study, 211 patients, including 138 lymphoma 66 myeloma who received CAR therapies were retrospectively identified. Of these, 42 (19.9%) developed CVAEs post-treatment. Myeloma...
To investigate whether the minimal cyclophosphamide equivalent dose (mCED), a novel approach for estimating alkylating agent exposure, is associated with sperm retrieval rates by microdissection testicular extraction (mTESE) in azoospermic postchemotherapy cancer survivors.